Originally published on November 6, 2013
University of Manitoba researchers have uncovered a gene that may be driving the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
The gene, known as TLS/FUS, is mutated in ALS patients. The mutant gene produces vast amounts of a faulty protein. Accumulation of the protein within cells is characteristic of the disease.
"Rather than turning off the production of a protein the cell knows is bad, it just keeps on plowing and plowing and plowing more, creating a worse situation," Geoff Hicks, director of the regenerative medicine program at the Winnipeg-based university, said in a CBC report.
Hicks' team at the university found a way to manipulate the cells to stop making the mutant protein.
Although it may take many years to develop this finding into an intervention, it has the potential to extend the lifespan of ALS patients, Hicks said.
ALS, also known as Lou Gehrigs disease after the famous New York Yankees baseball player who retired from the sport after developing the disease in 1939, is the progressive degeneration of motor neurons that control voluntary muscle movement.
TomoNews is your daily source for top animated news. We've combined animation and video footage with a snarky personality to bring you the biggest and best stories from around the world.
For news that's fun and never boring, visit our channel:https://www.youtube.com/user/TomoNewsUS
Subscribe to stay updated on all the top stories:http://www.youtube.com/subscription_center?add_user=TomoNewsUS
Stay connected with us here:
Twitter @tomonewsus http://www.twitter.com/TomoNewsUS